|
| Science Forum Index » Medicine - Cancer Forum » HER family (EGFR, Her2/neu/ERBB2...) inhibitors in... |
|
Page 1 of 1 |
|
| Author |
Message |
| scimedweb... |
 Posted: Sun Jul 05, 2009 10:10 pm |
|
|
|
Guest
|
HER family (EGFR, Her2/neu/ERBB2...) inhibitors in breast cancer
therapy
A detailed description of HER family (EGFR, Her2/neu/ERBB2...)
inhibitors (trastuzumab, lapatinib, gefitinib, erlotinib, pertuzumab,
cetuximab, ertumaxomab, neratinib, trastuzumab-MCC-DM1, BIBW 2992,
ARRY-334543) that are currently used in routine therapy or are in
clinical trials in breast cancer patients.
In « Molecular Therapy of Breast Cancer: Classicism Meets Modernity ».
by Marc Lacroix
InTextoResearch, Baelen (Liège, Wallonia), Belgium
Nova Sciences Publishers, New York, ISBN 978-1-60741-593-0
https://www.novapublishers.com/catalog/product_info.php?cPath=23_29&products_id=10042&osCsid=8fed1efc6158a0ba4004bec047b66ff0 |
|
|
| Back to top |
|
|
|
|
|
All times are GMT - 5 Hours
The time now is Sat Nov 28, 2009 3:47 pm
|
|
